Interleukin‐6: A Cytokine for Gerontolgists
暂无分享,去创建一个
[1] W. Ershler,et al. In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. , 1992, Cancer research.
[2] H. Broxmeyer,et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6 , 1992 .
[3] K S Kosik,et al. Alzheimer's disease: a cell biological perspective. , 1992, Science.
[4] G. Roodman. Perspectives: Interleukin‐6: An osteotropic factor? , 1992 .
[5] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[6] G. Passeri,et al. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. , 1992, The Journal of clinical investigation.
[7] J. Bauer,et al. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[8] M. Kluger,et al. Fever, tumor necrosis factor, and interleukin-6 in young, mature, and aged Fischer 344 rats. , 1992, The American journal of physiology.
[9] H. Broxmeyer,et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. , 1992, Science.
[10] J. Bauer,et al. IL-6-mediated events in Alzheimer's disease pathology. , 1991, Immunology today.
[11] H. Müller-Hermelink,et al. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. , 1991, The American journal of pathology.
[12] B. Klein,et al. Letter to the editor: The bone‐resorbing activity of interleukin‐6 , 1991 .
[13] M. Gowen. Reply: The bone‐resorbing activity of interleukin‐6 , 1991 .
[14] R. Effros,et al. Influence of age and caloric restriction on macrophage IL-6 and TNF production. , 1991, Lymphokine and cytokine research.
[15] W. Fiers,et al. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? , 1991, Immunology today.
[16] A. Kuramoto,et al. Interleukin-6 produced by renal-cell carcinoma cells and progression of multiple myeloma. , 1991, The New England journal of medicine.
[17] C. Masters,et al. In‐vitro matured human macrophages express Alzheimer's βA4‐amyloid precursor protein indicating synthesis in microglial cells , 1991, FEBS letters.
[18] K. Beyreuther,et al. Alpha 2‐macroglobulin synthesis in interleukin‐6‐stimulated human neuronal (SH‐SY5Y neuroblastoma) cells Potential significance for the processing of Alzheimer β‐amyloid precursor protein , 1991 .
[19] S. Akira,et al. Age-associated increase in interleukin 6 in MRL/lpr mice. , 1991, International immunology.
[20] S. Ralston,et al. Interleukin‐6 does not stimulate bone resorption in neonatal mouse calvariae , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] T. Hirano,et al. Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.
[22] T. Hirano,et al. IL-6 is produced by osteoblasts and induces bone resorption. , 1990, Journal of immunology.
[23] M. Jourdan,et al. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. , 1990, European cytokine network.
[24] A. Nienhuis,et al. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. , 1990, The Journal of clinical investigation.
[25] T. Suda,et al. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. , 1990, Journal of immunology.
[26] H. Potter,et al. α 1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α 1-antichymotrypsin , 1990, Neurobiology of Aging.
[27] M. Jourdan,et al. Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. , 1990, Arthritis and rheumatism.
[28] S. Rosenberg,et al. Antitumor activity of recombinant interleukin 6 in mice , 1990, The Journal of experimental medicine.
[29] J. Snick,et al. Interleukin-6: an overview. , 1990, Annual review of immunology.
[30] J. Radl,et al. Age-related monoclonal gammapathies: clinical lessons from the aging C57BL mouse. , 1990, Immunology today.
[31] T. Hirano,et al. Interleukin 6 (IL-6) , 1990, Biotherapy.
[32] G. Ciliberto,et al. Dual control of C‐reactive protein gene expression by interleukin‐1 and interleukin‐6. , 1989, The EMBO journal.
[33] T. Komori,et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease , 1989 .
[34] T. Hirano,et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.
[35] X. H. Wang,et al. A possible autocrine role for interleukin-6 in two lymphoma cell lines. , 1989, Blood.
[36] Masahiro Yamamoto,et al. Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas , 1989, FEBS letters.
[37] M. Jourdan,et al. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. , 1989, Blood.
[38] T. Komori,et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. , 1989, Blood.
[39] S. Akira,et al. Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. , 1988, Journal of immunology.
[40] R. Moritz,et al. Murine hybridoma/plasmacytoma growth factor. Complete amino-acid sequence and relation to human interleukin-6. , 1988, European journal of biochemistry.
[41] J. Vilček,et al. Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Taniguchi,et al. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. , 1988, Science.
[43] H. Asaoku,et al. Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma. , 1988, Blood.
[44] J. Vilček,et al. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. , 1988, The Journal of biological chemistry.
[45] S. Clark,et al. Multiple actions of interleukin 6 within a cytokine network. , 1988, Immunology today.
[46] H. Asaoku,et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas , 1988, Nature.
[47] P. Sehgal,et al. Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6). , 1988, Science.
[48] J. Ihle,et al. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[49] S. Clark,et al. B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[50] T. Hirano,et al. Structure and expression of human B cell stimulatory factor‐2 (BSF‐2/IL‐6) gene. , 1987, The EMBO journal.
[51] J H Korn,et al. Structure and expression of cDNA and genes for human interferon‐beta‐2, a distinct species inducible by growth‐stimulatory cytokines. , 1986, The EMBO journal.
[52] F. Ruddle,et al. Human chromosome 7 carries the beta 2 interferon gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[53] C. Frith,et al. Contributions of recent research to the classification of spontaneous lymphoid cell neoplasms in mice. , 1986, Critical reviews in toxicology.
[54] C. Taylor,et al. Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias. , 1983, The American journal of pathology.
[55] C. Frith,et al. Spontaneous lesions in virgin and retired breeder BALB/c and C57BL/6 mice. , 1983, Laboratory animal science.
[56] C. Frith,et al. Morphologic classification and correlation of incidence of hyperplastic and neoplastic hematopoietic lesions in mice with age. , 1981, Journal of gerontology.
[57] J. Radl,et al. Immunoglobulin patterns in humans over 95 years of age. , 1975, Clinical and experimental immunology.